October 16, 2020

New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Late-breaking results presented today confirm that incorporating the HeartFlow® FFRct Analysis into a coronary computed tomography angiogram (CTA)-led diagnostic pathway significantly increases overall cardiovascular treatment efficiency. At nine-months, the FORECAST trial demonstrated that a CTA-HeartFlow Analysis pathway led to a statistically significant decrease in invasive diagnostic coronary angiograms (ICA), an increase in efficiency in the cardiac


Leave Comment


Your Name *
Your Email *
Your Website
Comment *